STOKE THERAPEUTICS, INC.

Insiders Stoke Therapeutics, Inc.

Equities

STOK

US86150R1077

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
11.48 ^USD	-4.41%		-4.49%	+118.25%

05-07	Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating	MT
05-06	Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stoke Therapeutics Appoints Thomas Leggett CFO	04-29	MT
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer	04-17	CI
Stoke Therapeutics, Inc. Appoints Ian Smith to Board of Directors	23-09-20	CI
Insider Sell: Stoke Therapeutics	23-07-06	MT
Insider Sell: Stoke Therapeutics	23-02-07	MT
Stoke Therapeutics, Inc. Announces Resignation of Robin A. Walker, Senior Vice President, Chief Legal Officer and Chief Compliance Officer	20-11-12	CI
Stoke Therapeutics, Inc Announces Appointment of Garry E. Menzel to Both its Board of Directors and Compensation Committee	20-08-17	CI
Stoke Therapeutics, Inc. Appoints Julie Anne Smith to its Board of Directors	20-06-04	CI
Stoke Therapeutics, Inc. Announces Executive Appointments	19-10-16	CI
Stoke Therapeutics, Inc. Appoints Jennifer Burstein to Its Board of Directors	19-06-14	CI
Stoke Therapeutics Appoints Industry Veteran Stephen Tulipano as Chief Financial Officer	19-03-26	CI
Stoke Therapeutics, Inc. Announces Management Changes	18-12-18	CI
Stoke Therapeutics Appoints Arthur Tzianabos to Board of Directors	18-09-17	CI
Stoke Therapeutics, Inc. Announces Executive Appointments	18-04-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW